These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35264568)

  • 1. SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis.
    Zhang Y; Zhang T; Fang Y; Liu J; Ye Q; Ding L
    Signal Transduct Target Ther; 2022 Mar; 7(1):76. PubMed ID: 35264568
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 variant Omicron (B.1.1.529) is in a rising trend of mutations increasing the positive electric charge in crucial regions of the spike protein S.
    Pawłowski P
    Acta Biochim Pol; 2021 Dec; 69(1):263-264. PubMed ID: 34905671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
    Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
    Suzuki R; Yamasoba D; Kimura I; Wang L; Kishimoto M; Ito J; Morioka Y; Nao N; Nasser H; Uriu K; Kosugi Y; Tsuda M; Orba Y; Sasaki M; Shimizu R; Kawabata R; Yoshimatsu K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Sawa H; Ikeda T; Irie T; Matsuno K; Tanaka S; Fukuhara T; Sato K
    Nature; 2022 Mar; 603(7902):700-705. PubMed ID: 35104835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
    Kimura I; Yamasoba D; Nasser H; Ito H; Zahradnik J; Wu J; Fujita S; Uriu K; Sasaki J; Tamura T; Suzuki R; Deguchi S; Plianchaisuk A; Yoshimatsu K; Kazuma Y; Mitoma S; Schreiber G; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Takaori-Kondo A; ; Ito J; Shirakawa K; Takayama K; Irie T; Hashiguchi T; Nakagawa S; Fukuhara T; Saito A; Ikeda T; Sato K
    J Virol; 2023 Oct; 97(10):e0101123. PubMed ID: 37796123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
    Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
    Elife; 2021 Feb; 10():. PubMed ID: 33570490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
    Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
    J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Delta and Omicron variants resist spike cleavage by human airway trypsin-like protease.
    Ren W; Hong W; Yang J; Zou J; Chen L; Zhou Y; Lei H; Alu A; Que H; Gong Y; Bi Z; He C; Fu M; Peng D; Yang Y; Yu W; Tang C; Huang Q; Yang M; Li B; Li J; Wang J; Ma X; Hu H; Cheng W; Dong H; Lei J; Chen L; Zhou X; Li J; Wang W; Lu G; Shen G; Yang L; Yang J; Wang Z; Jia G; Su Z; Shao B; Miao H; Yiu-Nam Lau J; Wei Y; Zhang K; Dai L; Lu S; Wei X
    J Clin Invest; 2024 Sep; 134(18):. PubMed ID: 39286971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity.
    Jiang X; Zhang Z; Wang C; Ren H; Gao L; Peng H; Niu Z; Ren H; Huang H; Sun Q
    Signal Transduct Target Ther; 2020 Nov; 5(1):268. PubMed ID: 33203835
    [No Abstract]   [Full Text] [Related]  

  • 10. A Biochemical Perspective of the Nonstructural Proteins (NSPs) and the Spike Protein of SARS CoV-2.
    Yoshimoto FK
    Protein J; 2021 Jun; 40(3):260-295. PubMed ID: 33629236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review.
    Kannan S; Shaik Syed Ali P; Sheeza A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor.
    Lupala CS; Ye Y; Chen H; Su XD; Liu H
    Biochem Biophys Res Commun; 2022 Jan; 590():34-41. PubMed ID: 34968782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the SARS-CoV-2 spike protein in the human host.
    Wrobel AG; Benton DJ; Roustan C; Borg A; Hussain S; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
    Nat Commun; 2022 Mar; 13(1):1178. PubMed ID: 35246509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein.
    Heinzelman P; Romero PA
    PLoS One; 2021; 16(5):e0251585. PubMed ID: 33979391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike.
    Fang L; Kang X; Hong Q; Xue C; Pan L; Chen J; Tang C; Sun L; Xu X; Yuan J; Du Y; Xu A
    ACS Appl Mater Interfaces; 2024 Jun; 16(23):29716-29727. PubMed ID: 38814480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast-spreading U.K. virus variant raises alarms.
    Kupferschmidt K
    Science; 2021 Jan; 371(6524):9-10. PubMed ID: 33384355
    [No Abstract]   [Full Text] [Related]  

  • 20. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.